Intravenous Solutions Market Size Projected To Reach $20.51 Billion By 2034 With A Cagr Of 8%

The Intravenous Solutions Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Intravenous Solutions Market?
In recent times, there has been a notable surge in the size of the intravenous solutions market. It is projected to expand from $14 billion in 2024 to $15.05 billion in 2025, marking a compound annual growth rate (CAGR) of 7.5%. Factors that have contried to this growth in the past include an increase in surgical procedures, the rising prevalence of chronic illnesses, the development of home healthcare, strict regulations for product safety, a heightened emphasis on patient hydration, and initiatives for global emergency preparedness.

Expectations are that the intravenous solutions market will experience robust growth in the upcoming years. The projected market size will hit $20.51 billion in 2029, registering a compound annual growth rate (CAGR) of 8.0%. This growth during the forecast period can be linked to factors such as population expansion and aging, a surge in surgical interventions, an increase in the prevalence of infectious diseases, advances in telemedicine and remote patient monitoring, a focus on preventive healthcare, investments in global health security, and the trend towards patient-centric care. The forecast period is also set to witness significant trends such as the growing demand for parenteral nutrition solutions, a hike in the adoption of pre-mixed iv solutions, the broadening of home infusion therapies, the launch of electrolyte-balanced solutions, the development of innovative drug additives and adjuncts, and the integration of intelligent iv systems for observation.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13465

What Are the Different Intravenous Solutions Market Segments?
The intravenous solutions market covered in this report is segmented -

1) By Product: Total Parenteral Nutrition, Peripheral Parenteral Nutrition
2) By Nutrients: Carbohydrates, Vitamins And Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, Other Nutrients
3) By Application: Basic Intravenous (IV) Solution, Nutritional Intravenous (IV) Solution, Blood Intravenous (IV) Solution, Drug Intravenous (IV) Solution, Irrigation Intravenous (IV) Solution
4) By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings

Subsegments:
1) By Total Parenteral Nutrition (TPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions, Multivitamin Solutions
2) By Peripheral Parenteral Nutrition (PPN): Carbohydrate Solutions, Amino Acid Solutions, Lipid Solutions, Electrolyte Solutions

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13465&type=smp

What Are the Primary Drivers Shaping the Intravenous Solutions Market?
The escalation in cancer incidence is predicted to fuel the upward trend of the intravenous solutions market. Diseases grouped under the cancer umbrella are characterized by rampant cell growth, the capability to infiltrate neighboring tissues, and metastasize to other body regions. In cancer management, intravenous solutions are frequently utilized because they can administer chemotherapy drugs and ensure patients stay hydrated during treatment. To illustrate, the World Health Organization, a Switzerland-based international organization, predicted in February 2024 that by 2050, there would be more than 35 million new cancer cases, reflecting a 77% rise from the 20 million cases anticipated in 2022. Thus, the growing cancer rate is a primary factor in driving the uptake in the intravenous solutions market. Intravenous Solutions Market Driver: Intravenous Solutions Market Grows with Rise in Surgical Procedures

Which Companies Are Leading in the Intravenous Solutions Market?
Major companies operating in the intravenous solutions market report are Pfizer Inc., Abbott Laboratories, Eli Lilly and Company, Fresenius SE & Co. KGaA, Becton, inson and Company, Baxter International Inc., Otsuka Pharmaceutical Co. Ltd., CSL Limited, B. Braun Melsungen AG, Grifols S.A., Terumo Corporation, Nipro Corporation, Sichuan Kelun Pharmaceutical Co. Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, ICU Medical Inc., Gland Pharma Limited, Cisen Pharmaceutical Co. Ltd., Amsino International Inc., JW Life Science Co. Ltd., Eurolife Healthcare Pvt. Ltd., Huaren Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd., Claris Lifesciences Limited, Amanta Healthcare Ltd., Axa Parenterals Ltd., Wockhardt Ltd., Liqvor pharmaceuticals cjsc, Soxa Formulations & Research Pvt.Ltd., Aculife Healthcare Pvt. Ltd.

What Trends Are Expected to Dominate the Intravenous Solutions Market in the Next 5 Years?
Leading corporations in the intravenous solutions market are striving for uniqueness by innovating new types of syringes, like pre-filled and immediately usable ones, to gain an advantage over competitors. These no-fuss syringes come filled with medication and are ready to be used instantly, eliminating the need for manual filling. In a notable development in August 2023, GENIXUS Corp., a health company based in the US, introduced the KinetiXTM Rocuronium Bromide Injection in 5 mL and 10 mL variants of ready-to-administer (RTA) syringes. Crafted from a clear, sturdy polymer, these syringes eradicate the risks linked to glass ones. Beside efficiency, these syringes also ensure safety as they prevent medicinal errors. Rocuronium bromide injection is exclusively for intravenous application. Key features include being RFID-enabled via KitCheck for efficient kit and tray management, user-friendly labeling, and a color-distinguishing plunger rod for quick recognition.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

What Are the Top Revenue-Generating Geographies in the Intravenous Solutions Market?
North America was the largest region in the intravenous solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Intravenous Solutions Market?
2. What is the CAGR expected in the Intravenous Solutions Market?
3. What Are the Key Innovations Transforming the Intravenous Solutions Industry?
4. Which Region Is Leading the Intravenous Solutions Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.